Clinical trial
Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney…
NCT00177138 · University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00177138 |
|---|---|
| Title | Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation |
| Official title | Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Bayer Industry Gruessner, Rainer, MD |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Tacrolimus, Alemtuzumab |
| Enrollment | 9 |
| Start date | Jul 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: